View Author
patient study angioplasty stent group lesion artery infarction trial vessel angina result reperfusion procedure angiographic table heart stenting diameter occlusion 24 hours treatment cardiol balloon circulation revascularization percutaneou infarct size restenosi analysis outcome effect stenosi randomized stent implantation infarct event implantation percutaneous transluminal follow-up value intervention placebo disease hirudin flow reserve month predilatation difference complication angiography therapy measurement reserve luminal itf -1697 death heparin reperfusion injury contrast abciximab ischaemia culprit success target -1697 recoil angina pectoris transluminal baseline signi sirolimus-eluting injury number erasmus university rotterdam right luminal diameter 6 months sirolimus-eluting stents system
10 Most Recent Publications
|
Primary percutaneous coronary intervention by magnetic navigation compared with conventional wire technique
(Article)
Patterson, M.S. Dirksen, M.T. IJsselmuiden, A.J.J. Amoroso, G. Slagboom, T. Laarman, G-J. Schultz, C.J. Domburg, R.T. van Serruys, P.W.J.C. Kiemeneij, F. |
2011-06-01
|
|
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
(Article)
Dirksen, M.T. Laarman, G-J. Simoons, M.L. Duncker, D.J.G.M. |
2007-06-01
|
|
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
(Article)
Fajadet, J. Morice, M-C. Laarman, G-J. Perin, M.A. Sousa, J.E. Schuler, G. Molnar, F. Guagliumi, G. Colombo, A. Ban Hayashi, E. Wülfert, E. Barragan, P. Serruys, P.W.J.C. Wijns, W. Constantini, C. Guermonprez, J-L. Eltchaninoff, H. Blanchard, D. Bartorelli, A. |
2005-03-01
|
|
Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
(Article)
Ezechiels, J.P. Tijssen, J.G.P. Kiemeneij, F. Slagboom, T. Tangelder, G.J. Serruys, P.W.J.C. Laarman, G-J. IJsselmuiden, A.J.J. Wieken, L.R. van der Westendorp, I.C.D. |
2004-09-01
|
|
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty. Safety and efficacy of a novel tetrapeptide, ITF-1697
(Article)
Dirksen, M.T. Laarman, G-J. Giualiumi, G. Tonino, W.A.L. Tavazzi, L. Simoons, M.L. Hof, A.W.J. van 't Duncker, D.J.G.M. |
2004-03-01
|
|
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial
(Article)
Eltchaninoff, H. Guagliumi, G. Blanchard, D. Serruys, P.W.J.C. Abizaid, A.C. Albertal, M. Laarman, G-J. Morice, M-C. Abizaid, A.S. Sousa, A.G.M.R. Wülfert, E. Sousa, J.E. Lindeboom, W.K. Costa, M.A. |
2004-01-01
|
|
Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
(Article)
Cotton, J.M. Vaijifdar, B. Kiemeneij, F. Slagboom, T. Serruys, P.W.J.C. Laarman, G-J. Wieken, L.R. van der IJsselmuiden, A.J.J. Tangelder, G.J. |
2003-09-26
|
|
Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.
(Article)
Serruys, P.W.J.C. Scholte, A. Kiemeneij, F. Slagboom, T. Laarman, G-J. Wieken, L.R. van der Tangelder, G.J. IJsselmuiden, A.J.J. |
2003-03-01
|
|
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
(Article)
Brand, M.J.B.M. van den Laarman, G-J. Steg, P.G. Scheerder, I.K. de Heyndrickx, G.R. Beatt, K.J. Kootstra, J.G. Simoons, M.L. |
1999-11-19
|
|
A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
(Article)
Serruys, P.W.J.C. Herrman, J.P.R. Simon, R. Rutsch, W.R. Bode, C. Laarman, G-J. Dijk, R.B. van Bos, A.A. van den Umans, V.A.W.M. Fox, K.A.A. |
1995-01-01
|
